Anti-glutamic acid decarboxylase antibody (GAD) syndromes may have more aggressive disease course in African Americans and early onset of presentation compare to Caucasians group.
Sriwastava S, Srinivas M, Kanna A, Yarraguntla K, Jowkar A, George E.
Daif A, Lukas RV, Issa NP, Javed A, VanHaerents S, Reder AT, Tao JX, Warnke P, Rose S, Towle VL, Wu S.
Epilepsy Behav. 2018 Mar;80:331-336. doi: 10.1016/j.yebeh.2018.01.021. Epub 2018 Feb 9.
PMID:29433947
Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response.
Farooqi MS, Lai Y, Lancaster E, Schmitt SE, Sachais BS.